|
| Human ANGPTL4/Angiopoietin-like 4 Protein (LTP10658) |
|
| LTP10658 |
|
| 100ug |
|
|
$293 In stock |
| Candidates for this common regulatory system include signals mediated by peroxisome proliferator-activated regulator and its response factor, angiopoietin-like 4. The expression and bioactivity of angiopoietin-like 4, an adipocytokine that was originally reported to have an angiogenic function, have been detected not only in the vascular system and adipose tissue but also in rheumatoid joints. |
| Recombinant Human ANGPTL4/Angiopoietin-like 4 Protein is expressed from Expi293 with His tag at the N-terminal. It contains Pro166-Ser406. |
|
| ANGPTL4/Angiopoietin-like 4 |
|
| Human |
|
| Q9BY76-1 |
|
| Pro166-Ser406 |
|
| The protein has a predicted MW of 28.2 kDa. Due to glycosylation, the protein migrates to 30-40 kDa based on the Tris-Bis PAGE result. |
|
| The affinity constant of 13.8nM as determined in SPR assay (Biacore T200). See testing image for detail. |
|
| N-His |
|
| Expi293 |
|
| > 95% as determined by Tris-Bis PAGE; > 95% as determined by HPLC |
|
| Less than 1EU per ug by the LAL method. |
|
| Lyophilized from 0.22 um filtered solution in PBS (pH 7.4). Normally 5% trehalose is added as a protectant before lyophilization. |
|
| Reconstituted protein stable at -80 C for 12 months, 4 C for 1 week. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. |
|
| Shipped at ambient temperature. |
|
| Centrifuge tubes before opening. Reconstituting to a concentration of more than 100 ug/ml is recommended. Dissolve the lyophilized protein in distilled water. |
|
|  |
